In short
- Researchers reviewed 44 clinical trials of psilocybin, LSD and DMT for mental health, with 1,537 participants in total.
- Nearly all followed the same three phases: preparation, the dosing session and integration.
- But the therapy around the sessions ranged from none at all to 17 extra sessions, and from simple support to full therapies such as ACT or CBT.
What the researchers did
A team of researchers searched the medical literature for trials of classic psychedelics for psychiatric symptoms and recorded how each one built its psychological support: how many sessions, what kind of therapy and how it was adapted to the condition being treated.
What they found
The trials covered depression (20), addiction (8), distress linked to serious illness (8), anxiety (2) and other conditions. The dosing itself was increasingly standardised. The therapy was not: some trials offered almost nothing beyond the session, others offered weeks of structured work. Support was often tailored, such as motivational work for addiction or existential themes for people facing serious illness.
Why it matters
A psychedelic is never taken in a vacuum. Who is with you, how well you were prepared and what happens in the weeks afterwards all shape the experience and what comes of it. The authors point out that we still cannot separate the effect of the substance from the effect of the care around it, and that the context may affect both safety and benefit. This is the heart of how we work: every retreat has preparation, the retreat itself and integration, led by psychologists and psychotherapists.
Keep in mind
A review can only describe what trials reported. It does not show which approach works best, and many trials gave too little detail about their therapy to compare them properly.
Experience it for yourself
Our small-group retreats combine careful preparation, ceremonies and integration, led by psychologists and psychotherapists.
See our retreatsThis summary is for information only and is not medical advice. Psychedelics are controlled substances in many countries, including the UK.
You may also like
Why Integration After a Psilocybin Retreat Matters
A Dutch study followed 50 guests of psilocybin truffle retreats who went on to psychotherapy. Their wellbeing kept improving after the retreat ended.
Danielle Tanner · 17 July 2026
ResearchBelonging, Gratitude and Purpose: Beyond Symptom Relief
In an MDMA-assisted therapy trial for social anxiety, moments of connection and self-transcendent emotion predicted greater belonging, gratitude and purpose.
Danielle Tanner · 10 November 2026
ResearchKinder to Ourselves: Self-Compassion and Lasting Change After MDMA Therapy
In MDMA-assisted therapy for social anxiety, self-compassion rose during sessions and kept growing, and it was linked with less shame and more belonging.
Danielle Tanner · 3 November 2026
